Clinical Trials in Atlanta

Showing 6221-6240 of 19,805 trials

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

NCT03368963

This phase I/II trial studies the best dose and how well trifluridine/tipiracil hydrochloride combination agent TAS-102 (TAS-102) and nanoliposomal irinotecan work in treating patients with gastrointestinal cancers that have spread to other places in the body (metastatic) or cannot be removed by surgery. Drugs used in the chemotherapy, such as trifluridine/tipiracil hydrochloride combination agent TAS-102 and nanoliposomal irinotecan, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

Colorectal AdenocarcinomaGastric AdenocarcinomaMetastatic Pancreatic Adenocarcinoma+11 more

Emory University64 participantsStarted Jan 2018

Atlanta, Georgia, United States • Atlanta, Georgia, United States • Atlanta, Georgia, United States

COMPLETEDNA< 1 mile

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

NCT03222128

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN 3 transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, and severe aortic stenosis, and those with intermediate risk.

Symptomatic Severe Aortic Stenosis

Edwards Lifesciences1,074 participantsStarted Feb 2014

La Jolla, California, United States • Los Angeles, California, United States • Sacramento, California, United States +48 more locations

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - S3 Intermediate

Find Trials by Condition in Atlanta

Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.

A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

A Study to Investigate Efficacy and Safety of KBL697 in Patients with Moderate Plaque Type Psoriasis

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Study of AMG 994 Monotherapy and AMG 994 and AMG 404 Combination Therapy in Participants With Advanced Solid Tumors

Vivacit-E Post-market Follow-up Study

A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

NexGen TM Tibia Clinical Outcomes Study

Kerecis Real-World Fish Skin Graft Registry

ANC-501 in the Treatment of Adults With Major Depressive Disorder

A Study Evaluating the Safety and Efficacy of HB0036 in Subjects With Advanced Solid Tumors

Study to Measure Cerebrospinal Fluid Mutant Huntingtin Protein in Participants With Early Manifest Stage I or Stage II Huntington's Disease

The Perceptual Experience of Argus II Users

Philips Intracardiac Echocardiography (ICE) Clinical Registry

Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations

A Phase I/II Study of AZD0466 as Monotherapy or in Combination With Anticancer Agents in Advanced Non-Hodgkin Lymphoma

Predictive Factors for Medullary Thyroid Cancer Aggressiveness